期刊文献+

TIMP-3和RASSF1A在大肠癌中的表达及临床意义 被引量:1

Clinical significance of TIMP-3 and RASSF1A expression in colorectal cancer
下载PDF
导出
摘要 目的:探讨TIMP-3和RASSF1A在大肠癌发生发展中的作用及与临床病理特征之间的关系,并且研究TIMP-3和RASSF1A之间的相关性.方法:应用免疫组织化学法检测大肠癌组织,大肠癌旁组织及正常大肠黏膜组织中TIMP-3和RASSF1A蛋白的表达量并结合患者的年龄、性别、分化程度、淋巴结转移等临床病理因素进行综合分析.采用Spearman等级相关分析TIMP-3和RASSF1A之间的相关性.结果:在正常大肠黏膜、癌旁和腺癌中TIMP-3的阳性率分别为90.0%、70.0%和16.7%,RASSF1A阳性率分别为83.3%、63.3%和23.3%.大肠癌中TIMP-3和RASSF1A的表达量与淋巴结转移(P<0.05;P<0.01)、浸润深度(P<0.05;P<0.01)及分化程度(P<0.05;P<0.05)有关.运用Spearman等级相关分析,TIMP-3和RASSF1A的表达呈正相关(r=0.256,P<0.05).结论:在大肠癌中TIMP-3和RASSF1A具有明显相关性,TIMP-3和RASSF1A的表达下调可能与大肠癌的发生有关,可以作为鉴别大肠良恶性肿瘤的指标. AIM:To investigate the correlation between TIMP-3 and RASSF1A expression and clinicopathologic features of colorectal cancer.METHODS:The expression of TIMP-3 and RASSF1A was detected by immunohistochemistry in colorectal cancer,tumor-adjacent colorectal tissue and normal colorectal tissue specimens.The correlation between TIMP-3 and RASSF1A expression and clinicopathologic features,such as patient's age,gender,infiltration degree,and lymph node metastasis,was analyzed.The correlation between TIMP-3 and RASSF1A expres-sion was also determined by spearman's rank correlation analysis.RESULTS:The positive rates of TIMP-3 expression in normal colorectal mucosa,tumor adjacent tissue and colorectal cancer were 90.0%,70.0% and 16.7%,respectively,and those of RASSF1A were 83.3%,63.3% and 23.3%.In colorectal cancer,the expression of TIMP-3 and RASSF1A was related to lymph node metastasis,depth of invasion,and degree of tumor differentiation(all P 0.05).Spearman rank correlation analysis showed that there is a positive correlation between TIMP-3 and RASSF1A expression in colorectal adenocarcinoma(r = 0.256,P 0.05).CONCLUSION:The expression of TIMP-3 is signif icantly correlated with that of RASSF1A in colorectal cancer.The down-regulation of TIMP-3 and RASSF1A may be involved in the genesis of colorectal cancer and may be used as an index for evaluation of tumor malignancy.
出处 《世界华人消化杂志》 CAS 北大核心 2012年第27期2642-2647,共6页 World Chinese Journal of Digestology
关键词 TIMP-3 RASSF1A 大肠癌 免疫组织化学 TIMP-3 RASSF1A Colorectal cancer Immunohistochemistry
  • 相关文献

参考文献29

  • 1Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002; 22: 4309-4318. 被引量:1
  • 2Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 2000; 275: 35669-35672. 被引量:1
  • 3Deryugina EI, Soroceanu L, Strongin AY. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 2002; 62: 580-588. 被引量:1
  • 4DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, Hendrix MJ, Coussens L, Padarathsingh M. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am J Pathol 2004; 164: 1131-1139. 被引量:1
  • 5Qi JH, Anand-Apte B. Tissue inhibitor of metalloproteinase-3 (TIMP-3) suppresses VEGF receptor-2 mediated signaling independent of metalloproteinase inhibition. Invest Ophthalmol Vis Sci 2002, 43: 2753-2761. 被引量:1
  • 6Takahashi T, Nakamura T, Hayashi A, Kamei M, Nakabayashi M, Okada AA, Tomita N, Kaneda Y, Tano Y. Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells. Am J Ophthalmol 2000; 130: 774-781. 被引量:1
  • 7Murata T, Cui J, Taba KE, Oh JY, Spee C, Hinton DR, Ryan SJ. The possibility of gene therapy for the treatment of choroidal neovascularization. Ophthalmology 2000; 107: 1364-1373. 被引量:1
  • 8Mino N, Takenaka K, Sonobe M, Miyahara R, Yanagihara K, Otake Y, Wada H, Tanaka F. Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer. J Surg Oncol 2007; 95: 250-257. 被引量:1
  • 9Mylona E, Magkou C, Giannopoulou I, Agrogiannis G, Markaki S, Keramopoulos A, Nakopoulou L. Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome. Breast Cancer Res 2006; 8: R57. 被引量:1
  • 10刘丽,刘颖,贾立敏,贺业春,谢遵江.MMP-3、TIMP-3在人胃癌组织中的表达及意义[J].现代生物医学进展,2008,8(1):87-89. 被引量:2

二级参考文献57

共引文献20

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部